TELA Bio (TELA) Receivables - Net (2018 - 2026)

TELA Bio has reported Receivables - Net for 9 years, with the latest figure at $9.7 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net fell 7.98% year-over-year to $9.7 million; the trailing twelve-month figure through Mar 2026 stood at $9.7 million (down 7.98% YoY), and the FY2025 full-year result was $10.3 million, up 2.47% from the prior year.
• Receivables - Net for Q1 2026 stood at $9.7 million, down from $10.3 million in the prior quarter.
• The five-year high for Receivables - Net was $11.3 million in Q3 2025, with the low at $4.3 million in Q1 2022.
• Average Receivables - Net over 5 years is $8.7 million, with a median of $9.7 million recorded in 2026.
• Year-over-year, Receivables - Net soared 59.19% in 2022 and slipped 7.98% in 2026.
• Tracing TELA's Receivables - Net over 5 years: stood at $6.6 million in 2022, then surged by 47.06% to $9.7 million in 2023, then increased by 3.71% to $10.1 million in 2024, then advanced by 2.47% to $10.3 million in 2025, then slipped by 6.11% to $9.7 million in 2026.
• The last three Receivables - Net figures came in at $9.7 million (Q1 2026), $10.3 million (Q4 2025), and $11.3 million (Q3 2025), per Business Quant data.

Peer Comparison